AdaptHealth Corp. (AHCO) Misses Q2 EPS by 6c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall St falls as tech earnings spark AI spending worries and oil hits $100
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- RTX stock jumps as company lifts guidance after Q2 beat
UBS Reiterates Buy Rating on AdaptHealth (AHCO)
August 8, 2024 9:31 AM EDTUBS analyst Kevin Caliendo reiterated a Buy rating and $13.00 price target on AdaptHealth (NASDAQ: AHCO).
The analyst comments "AHCO's fundamentals remain relatively stable, the company appears to be gaining some market share, and margins are holding steady. The CGM shift to pharmacy (now 20% of the market) has... More
